Risk factor
My Bookmarks
As you browse, bookmark any page and then find it here for easy reference.
You have 0 bookmarks.
Focusing on violence from assessment, through underlying neurobiology, to treatment and other recommendations for practice, this book will be of interest to forensic psychiatrists, general adult psychiatrists, psychiatric residents, psychologists, psychiatric social workers and rehabilitation therapists.
As you browse, bookmark any page and then find it here for easy reference.
You have 0 bookmarks.
A catalog record for this publication is available from the British Library
|
|
Chapter 29 Comorbid mental illness and criminalness: implications for housing and treatment Robert D. Morgan and Nicole R. Bartholomew
The general public is misinformed about the relationship of mental illness to crime and violence, and believes that individuals with mental illness are dangerous [1,2]. It is not uncommon to see individuals with mental illness portrayed as violent, and violent acts are often attributed to mental illness. This happens in popular media (e.g., movies), as well as in news media following acts of violence such as the shootings in the Aurora, Colorado, movie theater and Sandy Hook Elementary School. In fact, following instances of violence, it seems almost inevitable that the mental health of a violent perpetrator is called into question by media outlets. This is in spite of the fact that media sources are notoriously unreliable with regard to reporting on the association of mental illness with violence [3,4]. The inaccurate link drawn by media outlets may be largely responsible for the “increase in the proportion of persons who associate persons with mental illness with dangerousness, violence, and unpredictability” (p. 39) [5]. Despite general misconceptions in the general public and media outlets regarding mental illness and violence, persons with mental illness (PMI) minimally contribute to overall rates of violence [6], and violent behavior in PMI is most common when other risk factors for violence are present (e.g., substance abuse, history of violence) [7].
In this chapter, we review the evidence regarding the association between mental illness and violence specifically, and mental illness and crime generally. The biopsychosocial factors that assist in differentiating which PMI will become violent and involved in crime will be discussed. Particular emphasis will be placed on the neurobiological underpinnings of violence, the role of criminal thinking (see Table 29.1), and the relationship between such antisocial cognitions
Risk factor
Description
History of antisocial behavior
Early onset and continued involvement in antisocial activities
Antisocial personality traits
Impulsivity, deceitfulness, disregard of the rights of others, lack of remorse, failure to conform to social norms, aggressiveness
Criminal thinking
Maladaptive thought patterns that serve to increase and sustain one’s propensity to engage in criminal behavior
Criminal associates
Peer group composed of individuals engaged in antisocial activities with a limited number of prosocial contacts
Substance abuse
Use of alcohol and/or other illicit substances
Family/marital problems
Poor or conflictual relationships with family and/or spouse
Poor work/school performance
Poor performance in the completion of work or school tasks; low work/school satisfaction
Lack of prosocial leisure activities
Few, if any, prosocial hobbies or interests
Mario Amore
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy
Allen Azizian
Coalinga State Hospital, Coalinga, and Department of Criminology, California State University, Fresno, California, USA
Shannon M. Bader
California Department of State Hospitals, and Patton State Hospital, California, USA
Michael W. Barsom
Department of State Hospitals (DSH) – Metropolitan, Norwalk, California, USA
Nicole R. Bartholomew
Psychology Services, Federal Bureau of Prisons, Big Spring, Texas, USA
Amlan Basu
Broadmoor High Secure Hospital, West London Mental Health NHS Trust, and Institute of Psychiatry, King’s College, London, UK
Charles Broderick
California Department of State Hospitals, Sacramento, California, USA
Rosalie S. Brooman-White
Medical Sciences Division, John Radcliffe Hospital, University of Oxford, Oxford, UK
Darcy Brown
The School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK
Leslie Citrome
Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York, USA
Emil F. Coccaro
Clinical Neuroscience & Psychopharmacology Research Unit, Department of Psychiatry (MC#3077), Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA
Michael A. Cummings
Department of State Hospitals–Patton, Department of Psychiatry, Patton, California, USA; Department of Psychiatry and Human Behavior, University of California, Irvine, Orange, California, USA
Stephen E. Cummings
Department of Psychiatry, San Mateo Medical Center, San Mateo, California, USA
Pál Czobor
Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary
Laura J. Dardashti
California Department of State Hospitals, and Metropolitan State Hospital, California, USA
Mrigendra Das
Broadmoor Hospital, West London Mental Health Trust, Berkshire, amd School of Psychiatry, Oxford Deanery, Oxford, UK
Darci Delgado
California Department of State Hospitals, and Vacaville Psychiatric Program, California, USA
Sean E. Evans
Psychology Department, Department of State Hospitals, Patton, California, and Psychology Department, La Sierra University, Riverside, California, USA
Thomas Fahy
Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Jennifer R. Fanning
Clinical Neuroscience & Psychopharmacology Research Unit, Department of Psychiatry (MC#3077), Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA
Alan R. Felthous
Division of Forensic Psychiatry, Department of Neurology & Psychiatry, Saint Louis University School of Medicine, Saint Louis, Missouri, USA
E. Fuller Torrey
Department of Psychiatry, Uniformed Services University of the Health Sciences (USUHS), Bethesda, Maryland, USA; Stanley Medical Research Institute, Chevy Chase, Maryland, USA
David Goldman
Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA
Jordan H. Grafman
Rehabilitation Institute of Chicago, Chicago, Illinois, USA
Nitin Gupta
Department of Psychiatry, Government Medical College and Hospital, Chandigarh, India
Margaret Guyer
Central Office Research Review Committee, Massachusetts Department of Mental Health, Massachusetts Mental Health Center Division of Public Psychiatry, and Harvard Medical School/Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Colin A. Hodgkinson
Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA
Brian J. Holoyda
Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, California, USA
Matthew J. Hoptman
Schizophrenia Research Division, Nathan Kline Institute for Psychiatric Research, Orangeburg, Department of Psychiatry, New York, USA, and University School of Medicine, and Department of Psychology, City University of New York, New York, USA
Deborah Horowitz
Office of Training and Development, Massachusetts Department of Mental Health, Westborough, Massachusetts, USA
James E. Hotham
Medical Sciences Division, John Radcliffe Hospital, University of Oxford, Oxford, UK
Sharon A. Humphreys
Broadmoor High Secure Hospital, West London Mental Health NHS Trust, London, UK
James L. Knoll IV
Division of Forensic Psychiatry, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, USA
Rebecca Kornbluh
California Department of State Hospitals, Sacramento, California, USA
Frank Krueger
Molecular Neuroscience Department, George Mason University, Fairfax, and Department of Psychology, George Mason University, Fairfax, Virginia, USA
Fintan Larkin
Broadmoor Hospital, West London Mental Health Trust, Berkshire, UK
Royce Lee
Clinical Neuroscience & Psychopharmacology Research Unit, Department of Psychiatry (MC#3077), Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA
K. Luan Phan
Department of Psychiatry, University of Illinois College of Medicine, Mental Health Service Line, Jesse Brown Veterans Administration Medical Center, and Departments of Psychology, and Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois, USA
Barbara E. McDermott
Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, California, USA
Jonathan M. Meyer
Department of Psychiatry, University of California–San Diego, San Diego, California Department of State Hospitals, and Patton State Hospital, California, USA
John Monahan
School of Law, University of Virginia, Charlottesville, Virginia, USA
Robert D. Morgan
Department of Psychological Sciences, Texas Tech University, Lubbock, Texas, USA
Debbi A. Morrissette
Neuroscience Education Institute, Carlsbad, California, Department of Biology, California State University, San Marcos, California, and Department of Biology, Palomar College, San Marcos, California, USA
Jennifer A. O’Day
California Department of State Hospitals, and Metropolitan State Hospital, California, USA
Mark E. Olver
Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Matteo Pardini
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, and Magnetic Resonance Research Centre on Nervous System Diseases, University of Genoa, Genoa, Italy
Debra A. Pinals
Law and Psychiatry Program, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, USA
George J. Proctor
California Department of State Hospitals, and Patton State Hospital, California, USA
Cameron D. Quanbeck
Department of Psychiatry, San Mateo Health System, San Mateo, California, USA
Vanessa Raymont
Department of Medicine, Imperial College London, London, UK
Phillip J. Resnick
Division of Forensic Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
Jose L. Romero-Ureclay
Broadmoor Hospital, West London Mental Health Trust, Berkshire, UK
Benjamin Rose
California Department of State Hospitals, and Napa State Hospital, California, USA
Daniel R. Rosell
Department of Psychiatry, Icahn Medical School, Mount Sinai, New York, and Special Evaluation Program of Mood and Personality Disorders, Icahn Medical School, Mount Sinai, New York, USA
Callum C. Ross
Broadmoor Hospital, West London Mental Health Trust, Berkshire, UK
Kathy Sanders
Clinical and Professional Services, Massachusetts Department of Mental Health, and Harvard Medical School/Massachusetts General Hospital, Boston, Massachusetts, USA
Robert J. Schaufenbil
California Department of State Hospitals, Sacramento, California, USA
Marie Schur
California Department of State Hospitals, and Atascadero State Hospital, California, USA
Eric H. Schwartz
California Department of State Hospitals, and Vacaville Psychiatric Program, California, USA
Charles L. Scott
Division of Psychiatry and the Law, Department of Psychiatry and Behavioral Sciences, University of California–Davis School of Medicine, 5 Sacramento, California, USA
Samrat Sengupta
Broadmoor Hospital, West London Mental Health Trust, Berkshire, UK
Larry J. Siever
Department of Psychiatry, and Special Evaluation Program of Mood and Personality Disorders, Icahn Medical School, Mount Sinai, New York, and Department of Psychiatry and the VISN3 Mental Illness Research, Education, and Clinical Center (MIRECC), James J. Peters VA Medical Center, Bronx, New York, USA
Patrick J. D. Simpson
Medical Sciences Division, John Radcliffe Hospital, University of Oxford, Oxford, UK
Jennifer L. Skeem
School of Social Welfare & Goldman School of Public Policy, University of California–Berkeley, Berkeley, California, USA
Stephen M. Stahl
California Department of State Hospitals, Sacramento, University of California San Diego, California, USA, and University of Cambridge, Cambridge, UK
Maren Strenziok
Department of Psychology, George Mason University, Fairfax, Virginia, USA
Katalin A. Szabo
Department of Psychiatry, San Mateo Health System, San Mateo, and Behavioral Health and Recovery Services, San Mateo, and Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA
John Tully
Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Richard A. Van Dorn
Research Triangle Institute International, Research Triangle Park, Durham, North Carolina, USA
Susan Velasquez
California Department of State Hospitals, and Patton State Hospital, California, USA
Morris Vinestock
Broadmoor Hospital, West London Mental Health Trust, Berkshire, UK
Jan Volavka
Department of Psychiatry, New York University School of Medicine, New York, USA
Raziya S. Wang
Behavioral Health and Recovery Services, San Mateo, California, USA
Katherine D. Warburton
California Department of State Hospitals, Sacramento, and Division of Psychiatry and the Law, University of California, Davis, California, USA
Eric M. Wassermann
Behavioral Neurology Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
Christopher L. White
Department of Psychiatry, San Mateo Health System, San Mateo, and Behavioral Health and Recovery Services, San Mateo, California, USA
Stephen C. P. Wong
Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, School of Medicine, University of Nottingham, Nottingham, UK, and Centre for Forensic Behavioural Science, Swinburne University of Technology, Melbourne, Australia